SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 147 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $25,000 | -32.4% | 222,700 | +953.9% | 0.00% | 0.0% |
| Q2 2018 | $37,000 | +94.7% | 21,131 | +102.1% | 0.00% | – |
| Q1 2018 | $19,000 | -71.2% | 10,457 | -26.1% | 0.00% | -100.0% |
| Q1 2017 | $66,000 | -58.2% | 14,146 | -52.4% | 0.00% | -75.0% |
| Q3 2015 | $158,000 | -24.0% | 29,740 | -60.2% | 0.00% | -60.0% |
| Q3 2014 | $208,000 | – | 74,803 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |